Cathepsin D deficiency is a fatal neurodegenerative disease characterized by extreme loss of neurons and myelin. Our previous studies have demonstrated that structural and functional alterations in synapses are central to the disease pathogenesis. Therefore, we took a systematic approach to examine the synaptic proteome in cathepsin D knock-out mice, where the synaptic pathology resembles that of human patients. We applied quantitative mass spectrometry analysis on synaptosomal fractions isolated from cathepsin D knock-out and control mice at the age of 24 days. From the approximately 600 identified proteins, 43 were present in different amounts (P b 0.05, measured in triple biological replicates) in cathepsin D knock-out mice compared to controls. We connected and bridged these 43 proteins using protein interaction data, and overlaid the network with brain specific gene expression information. Subsequently, we superimposed the network with Gene Ontology, pathway, phenotype and disease involvement, allowing construction of a dynamic, disease-protein centered network and prediction of functional modules. The measured changes in the protein levels, as well as some of the bioinformatically predicted ones, were confirmed by quantitative Western blotting or qualitative immunohistochemistry. This combined approach indicated alterations in distinct cellular entities, previously not associated with the disease, and including microtubule associated cytoskeleton and cell projection organization. Cell spreading and wound healing assays confirmed strongly compromised spatial orientation, associated with changes in distribution of focal adhesions and integrin assembly, in cathepsin D deficient cells. These changes might contribute to commencement of synaptic alterations and neuronal degeneration observed in cathepsin D deficiency.
Introduction
Mutations in cathepsin D (CTSD) gene underlie the congenital neuronal ceroid-lipofuscinosis (CLN10, OMIM: 610127), a devastating neurodegenerative disease in newborn babies (Fritchie et al., 2009; Siintola et al., 2006) . Cathepsin D (CathD) deficiency is the most severe and early-onset form of neuronal ceroid-lipofuscinosis (NCL), a group of inherited progressive neurodegenerative diseases with variable onset (Kohlschutter and Schulz, 2009 ). At present, at least nine causal genes with more than 365 mutations (http://www.ucl. ac.uk/ncl) have been described for NCLs (Kohan et al., 2011; Kousi et al., 2012; Noskova et al., 2011) and several more are predicted to exist (http://www.ncl2012.org/). Despite the genetic heterogeneity, the NCLs share certain clinical features including epilepsy, visual loss caused by retinal degeneration, and most importantly, progressive psychomotor decline (Kohlschutter and Schulz, 2009) . Infants with CathD deficiency are severely affected already at birth; they have epilepsy, poor respiratory and cardiac functions, and die within a few days (Fritchie et al., 2009; Norman and Wood, 1941; Siintola et al., 2006) . The neuropathological findings include microencephaly, excessive neuronal loss, demyelination, generalized gliosis and accumulation of storage material within cells throughout the cerebral cortex (Fritchie et al., 2009; Norman and Wood, 1941; Siintola et al., 2006; Tyynela et al., 2000) . E-mail addresses: maciej.lalowski@helsinki.fi (M. Lalowski), jaana.tyynela@helsinki.fi (J. Tyynelä).
Available online on ScienceDirect (www.sciencedirect.com). 1 Deceased. 2 Equal contribution.
